Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Eye Neoplasms × Peptides × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 3 Skin Neoplasms 2 Uveal Melanoma 1 Myelodysplastic Syndromes 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Eye Neoplasms 1

Interventions

Vincristine 1 Topotecan 1 Proton Therapy 1 Peptides 1 MAGEA3 protein, human 1 Leuprolide 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Eye Enucleation 1 Etoposide 1 Doxorubicin 1 D-methadone 1 Cyclophosphamide 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00254397 2019-10-16

Melanoma Vaccine With Peptides and Leuprolide

M.D. Anderson Cancer Center

Phase 2 Completed

98 enrolled 11 charts

Uveal Melanoma, Eye Neoplasms, Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡